INIS
animals
11%
antibiotics
23%
beta spectra
52%
capacity
5%
children
5%
communities
11%
comparative evaluations
17%
cost
11%
data
5%
emergencies
5%
escherichia coli
17%
genes
5%
host
5%
infants
35%
mice
17%
morbidity
5%
mortality
5%
public health
5%
risks
11%
strains
100%
units
5%
Medicine and Dentistry
Absence
11%
Adverse Outcome
5%
Antibiotic Resistance
11%
Antibiotics
23%
Antiinfective Agent
17%
Aptitude
5%
Beta-Lactamase
5%
Child
5%
Chronic Disease
5%
Commensal Escherichia Coli
5%
Emergency
5%
Escherichia coli
41%
Extended Spectrum Beta Lactamase
47%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
5%
Fitness
17%
Gene
5%
Gut
35%
Health Care Cost
11%
Immunocompromised Patient
5%
Infant
29%
Infection
11%
Life
11%
Morbidity
5%
Mortality
5%
Neonatal Intensive Care Unit
5%
Prematurity
5%
Public Health
5%
Thinking
5%
Whole Genome Sequencing
5%
Immunology and Microbiology
Animal
11%
Antimicrobial Resistance
11%
Aptitude
5%
Commensal Escherichia Coli
5%
Escherichia coli
41%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
5%
Fitness
17%
Gene
5%
Health
5%
Immunocompromised Patient
5%
Life
11%
Morbidity
5%
Mortality
5%
Mouse
11%
Mouse Model
5%
Pressure
5%
Spectrum
47%
Thinking
5%
Whole Genome Sequencing
5%